Skip to main content
. 2021 Dec 1;32(12):1019–1028. doi: 10.5152/tjg.2021.201171

Table 1.

Patient Demographics and Baseline Characteristics

Patient Demographics
Gender, n (%)
 Male 448 (81.9)
 Female 99 (18.1)
Age at diagnosis (years)
 Mean (SD) 62.6 (10.3)
 Median (min-max) 63.0 (19.0-92.0)
Age groups, n (%)
 19-39 years 9 (1.6)
 40-59 years 190 (34.8)
 60-69 years 206 (37.7)
 70-79 years 119 (21.8)
 ≥80 years 22 (4.0)
Body mass index (kg/m2), mean (SD, min-max) 25.9 (4.4,16.1-44.4)
BMI category, n (%)
 <25 kg/m2 255 (46.6)
 25-30 kg/m2 207 (37.8)
 >30 kg/m2 85 (15.5)
Comorbid diseases, n (%)1 236 (45.6)
Hypertension 129 (29.6)
Diabetes mellitus 100 (22.9)
CAD 46 (10.6)
COPD 14 (3.2)
Dyslipidemia 7 (1.6)
Other 140 (32.1)
Risk factors
Smoking status, n (%)2
 Active smoker 101 (18.7)
 Former smoker 200 (37.0)
 Non-smoker 205 (37.9)
 Package-year, mean (SD, min-max) 34.9 (12.0, 1.0-62.0)
Alcohol consumption, n (%)3
 Regular 42 (7.7)
 Former 104 (19.0)
 None 391 (71.5)
 Duration (years), median (min-max) (n = 99) 25.0 (3.0-60.0)
 Amount (units), median (min-max), (n = 102)* 15.0 (1.0-170.0)
Family history, n (%)4
Hepatitis
 Total 122 (22.5)
 In HBV + patients 83 (27.9)
 In HCV + patients 10 (10.9)
HCC
 Total 32 (6.3)
First-degree relatives 21 (72.4)
 Second-degree relatives 7 (24.1)
 Spouse 1 (3.4)
Other malignancies
 Total 124 (25.9)
 Lung 32 (25.8)
 GIS 28 (22.6)
 Hematological 11 (8.9)
 Breast 8 (6.5)
 Brain 8 (6.5)
 Other 37 (29.8)
Blood transfusion, n (%)5 77 (15.4)

CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease.

Missing data for 129, 235, 310, 469, and 547 patients.